Therapeutic Advances in Hematology

Papers
(The H4-Index of Therapeutic Advances in Hematology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias37
Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib36
Bortezomib in autoimmune hemolytic anemia and beyond27
Venetoclax-containing regimens in acute myeloid leukemia27
Current evidence and the emerging role of eltrombopag in severe aplastic anemia27
B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies26
Safety and efficacy of pegcetacoplan in paroxysmal nocturnal hemoglobinuria22
Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review20
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin)19
Primary central nervous system lymphoma in the United States, 1975–201719
Clinical features of DDX41 mutation-related diseases: a systematic review with individual patient data19
The potential of pirtobrutinib in multiple B-cell malignancies19
Voxelotor: alteration of sickle cell disease pathophysiology by a first-in-class polymerization inhibitor18
International consensus recommendations on the management of people with haemophilia B18
Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy18
Current and emerging treatment options in primary mediastinal B-cell lymphoma16
Update on the role of gemtuzumab-ozogamicin in the treatment of acute myeloid leukemia16
0.026991844177246